FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Dr. rer. nat. Tina Jost
Orcid ID:
0000-0001-8767-3774
List of publications:
BibTeX-Download
Lehrstuhl für Strahlentherapie
Department of Radiation Oncology
Project Memberships
(2)
Publications
(39)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Influence of CDK4/6 Inhibitors and Ionizing Radiation on Senescence in Breast Cancer Cells (2021)
Quarz L, Jost T, Fietkau R, Distel L
Conference contribution
Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells (2021)
Faulhaber EM, Jost T, Symank JA, Scheper J, Burkel F, Fietkau R, Hecht M, Distel L
Journal article
PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation (2021)
Jonuscheit S, Jost T, Gajdošová F, Wrobel M, Hecht M, Fietkau R, Distel L
Journal article
Dual mtor/dna-pk inhibitor cc-115 induces cell death in melanoma cells and has radiosensitizing potential (2020)
Bürkel F, Jost T, Hecht M, Heinzerling L, Fietkau R, Distel L
Journal article
Ex vivo radiosensitivity is increased in non-cancer patients taking valproate (2020)
Stritzelberger J, Lainer J, Gollwitzer S, Graf W, Jost T, Lang J, Müller T, et al.
Journal article
Senescence Induction by Combined Ionizing Radiation and DNA Damage Response Inhibitors in Head and Neck Squamous Cell Carcinoma Cells (2020)
Dobler C, Jost T, Hecht M, Fietkau R, Distel L
Journal article
Influence of the ALK Kinase Inhibitors Crizotinib and Alectinib on healthy and malignant Lung Cell Lines in a Combination Therapy with ionizing Radiation (2020)
Schultz AK, Jost T, Hecht M, Fietkau R, Distel L
Conference contribution
Effects of Combination Therapy of Kinase Inhibitors and ionizing Radiation on ENT Tumor Cell Lines and Normal Tissue Cells (2020)
Faulhaber EM, Scheper J, Jost T, Hecht M, Fietkau R, Distel L
Conference contribution
Comparison of different CDK4/6 Kinase Inhibitors (Palbociclib, Ribociclib, Abemaciclib) and their Influence on the Effectiveness of simultaneous Radiation Therapy (2020)
Jost T, Hecht M, Fietkau R, Distel L
Conference contribution
Influence of the ATR and ATM Kinase Inhibitors VE822 and AZD0156 on Melanoma Cell Lines in Combination Therapy with ionizing Radiation (2020)
Scheper JSS, Jost T, Faulhaber EM, Hecht M, Fietkau R, Distel L
Conference contribution
‹
1
2
3
4
›